Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Bi 425809
1. 1421936-85-7
2. Iclepertin [inn]
3. Bi-425809
4. M43zdu10dd
5. Unii-m43zdu10dd
6. Bi425809
7. Bi 425809
8. [5-methylsulfonyl-2-[(2r)-1,1,1-trifluoropropan-2-yl]oxyphenyl]-[(1r,5r)-1-[5-(trifluoromethyl)-1,2-oxazol-3-yl]-3-azabicyclo[3.1.0]hexan-3-yl]methanone
9. Methanone, (5-(methylsulfonyl)-2-((1r)-2,2,2-trifluoro-1-methylethoxy)phenyl)((1r,5r)-1-(5-(trifluoromethyl)-3-isoxazolyl)-3-azabicyclo(3.1.0)hex-3-yl)-
10. [5-?(methylsulfonyl)?-?2-?[(1r)?-?2,?2,?2-?trifluoro-?1-?methylethoxy]?phenyl]?[(1r,?5r)?-?1-?[5-?(trifluoromethyl)?-?3-?isoxazolyl]?-?3-?azabicyclo[3.1.0]?hex-?3-?yl]?-methanone
11. Methanone, [5-(methylsulfonyl)-2-[(1r)-2,2,2-trifluoro-1-methylethoxy]phenyl][(1r,5r)-1-[5-(trifluoromethyl)-3-isoxazolyl]-3-azabicyclo[3.1.0]hex-3-yl]-
12. Iclepertin [usan]
13. Iclepertin (jan/usan/inn)
14. Chembl5314576
15. Schembl22621289
16. Gtpl12110
17. Myhdqtvhhmslef-ddbgaenhsa-n
18. Glxc-25863
19. Ex-a9180
20. Akos040755624
21. Ms-29509
22. Hy-138935
23. Cs-0173438
24. D12527
25. G18229
26. En300-33036645
27. Z5066614506
28. (1r,5r)-3-(5-methanesulfonyl-2-{[(2r)-1,1,1-trifluoropropan-2-yl]oxy}benzoyl)-1-[5-(trifluoromethyl)-1,2-oxazol-3-yl]-3-azabicyclo[3.1.0]hexane
29. (5-(methylsulfonyl)-2-((r)-1,1,1-trifluoropropan-2-yloxy)phenyl)((1r,5r)-1-(5-(trifluoromethyl)isoxazol-3-yl)-3-azabicyclo[3.1.0]hexan-3-yl)methanone
30. [5-(methylsulfonyl)-2-[(1r)-2,2,2-trifluoro-1-methylethoxy]phenyl][(1r,5r)-1-[5-(trifluoromethyl)-3-isoxazolyl]-3-azabicyclo[3.1.0]hex-3-yl]-methanone
31. [5-(methylsulfonyl)-2-[(1r)-2,2,2-trifluoro-1-methylethoxy]phenyl][(1r,5r)-1-[5-(trifluoromethyl)-3-isoxazolyl]-3-azabicyclo[3.1.0]hex-3-yl]methanone
Molecular Weight | 512.4 g/mol |
---|---|
Molecular Formula | C20H18F6N2O5S |
XLogP3 | 3.5 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 12 |
Rotatable Bond Count | 5 |
Exact Mass | Da |
Monoisotopic Mass | Da |
Topological Polar Surface Area | 98.1 |
Heavy Atom Count | 34 |
Formal Charge | 0 |
Complexity | 907 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 3 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Treatment of schizophrenia
Nootropic Agents
Drugs used to specifically facilitate learning or memory, particularly to prevent the cognitive deficits associated with dementias. These drugs act by a variety of mechanisms. (See all compounds classified as Nootropic Agents.)
ABOUT THIS PAGE
91
PharmaCompass offers a list of Iclepertin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Iclepertin manufacturer or Iclepertin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Iclepertin manufacturer or Iclepertin supplier.
PharmaCompass also assists you with knowing the Iclepertin API Price utilized in the formulation of products. Iclepertin API Price is not always fixed or binding as the Iclepertin Price is obtained through a variety of data sources. The Iclepertin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Iclepertin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Iclepertin, including repackagers and relabelers. The FDA regulates Iclepertin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Iclepertin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Iclepertin supplier is an individual or a company that provides Iclepertin active pharmaceutical ingredient (API) or Iclepertin finished formulations upon request. The Iclepertin suppliers may include Iclepertin API manufacturers, exporters, distributors and traders.
Iclepertin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Iclepertin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Iclepertin GMP manufacturer or Iclepertin GMP API supplier for your needs.
A Iclepertin CoA (Certificate of Analysis) is a formal document that attests to Iclepertin's compliance with Iclepertin specifications and serves as a tool for batch-level quality control.
Iclepertin CoA mostly includes findings from lab analyses of a specific batch. For each Iclepertin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Iclepertin may be tested according to a variety of international standards, such as European Pharmacopoeia (Iclepertin EP), Iclepertin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Iclepertin USP).